21/03/2026
https://www.facebook.com/share/p/1ALVurpw52/
A guideline from the American College of Gastroenterology recommends rifabutin triple therapy or potassium-competitive acid blocker-based regimens for treatment-naive adults with infection unable to receive bismuth quadruple therapy.
https://ja.ma/4sYWwPe